Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mobile MRI Unit Reveals Effects of Endurance Running

By HospiMedica International staff writers
Posted on 30 Dec 2010
Using a mobile magnetic resonance imaging (MRI) unit, researchers followed runners for two months along a 4,500-km course to examine how their bodies responded to the high-stress conditions of an ultra-long-distance race.

The study's findings were presented at the annual meeting of the Radiological Society of North America (RSNA), November 2010 in Chicago, IL, USA. More...
"Due to the exceptional setting of this study, we could acquire huge amounts of unique data regarding how endurance running affects the body's muscle and body fat,” said Uwe Schütz, MD, a specialist in orthopedics and trauma surgery in the department of diagnostic and interventional radiology at the University Hospital of Ulm (Germany). "Much of what we have learned so far can also be applied to the average runner.”

The TransEurope-FootRace 2009 took place during April 19 to June 21, 2009. It started in southern Italy and traversed approximately 4,488 kilometers to the North Cape in Norway. Forty-four of the runners (66%) agreed to participate in the study. Urine and blood samples as well as biometric data were collected daily. The runners were also randomly assigned to other exams, including electrocardiograms, during the course of the study. Twenty-two of the runners in the study underwent a whole-body MRI exam approximately every three or four days during the race, totaling 15 to 17 exams over a period of 64 days. At the close of the race, researchers began to evaluate the data to determine, among other things, stress-induced changes in the legs and feet from running. Whole-body volume, body fat, visceral fat, abdominal subcutaneous adipose tissue (SCAT), and fat and skeletal muscle of the lower extremities were measured. Sophisticated MRI techniques allowed the researchers to quantify muscle tissue, fat, and cartilage changes. According to Dr. Schütz, MRI is the gold standard for the assessment of the musculoskeletal system of the runner.

The MRI scan results demonstrated that runners lost an average of 5.4% body volume during the course of the race, most of which was in the first 2,000 kilometers. They lost 40% of their body fat in the first half of the race and 50% over the duration of the race. Loss of muscle volume in the leg averaged 7%. "One of the surprising things we found is that despite the daily running, the leg muscles of the athletes actually degenerated because of the immense energy consumption,” Dr. Schütz said.

While most people do not run to this extreme, several of the study's other findings still have implications for the marathon runner and even the recreational runner, according to Dr. Schütz. For example, the results showed that some leg injuries are safe to "run through.” If a runner has intermuscular inflammation in the upper or lower legs, it is usually possible to continue running without risk of further tissue damage. Other overuse injuries, such as joint inflammation, carry more risk of progression, but not always with persistent damage. "The rule that ‘if there is pain, you should stop running' is not always correct,” Dr. Schütz said.

Another major finding of the study was that the first tissue affected by running was fat tissue. More significantly, visceral fat loss (mean 70%) occurred much earlier in the running process than previously believed. Visceral fat is the most dangerous fat and is linked to cardiovascular disease. The findings also revealed that the greatest amount of overall fat loss appeared early in the process.

"When you just begin running, the effects of fat reduction are more pronounced than in athletes who have been running their whole life,” Dr. Schütz concluded. "But you should do this sport constantly over the years. If you stop running for a long time, you need to reduce your caloric input or opt for other aerobic exercises to avoid experiencing weight gain.”

Related Links:

University Hospital of Ulm



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.